Arrowhead Pharmaceuticals (ARWR)'s 30-day implied volatility (IV30) was 53.9% at the close on November 10, 2026, down from 59.2% the day before, against a 52-week range of 42.8% to 88.1%. Its 20-day historical volatility was 55.0%.
Data as of November 10, 2026.